(Q51837831)

English

The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma.

scientific article published on 5 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

author name string

G F Lehnerdt

1

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

P Franz

2

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

A Bankfalvi

3

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

S Grehl

4

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

A Kelava

5

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

H Nückel

6

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

S Lang

7

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

K W Schmid

8

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

W Siffert

9

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

H S Bachmann

10

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

publication date

5 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

20

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

6

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

1094-1099

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

The Bcl2 family: regulators of the cellular life-or-death switch

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN763

21 January 2018

BCL2 family in DNA damage and cell cycle control

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN763

21 January 2018

Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN763

21 January 2018

Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN763

21 January 2018

Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN763

21 January 2018

A negative regulatory element in the bcl-2 5'-untranslated region inhibits expression from an upstream promoter

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN763

21 January 2018

Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN763

21 January 2018

Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN763

21 January 2018

Clinical and epidemiological data of patients with malignomas of the head and neck

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN763

21 January 2018

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN763

21 January 2018

The cellular concentration of Bcl-2 determines its pro- or anti-apoptotic effect

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN763

21 January 2018

Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix☆

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN763

21 January 2018

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN763

21 January 2018

Identifiers

10.1093/ANNONC/MDN763

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19196738

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51837831&oldid=1314842946"